One-Year Outcomes in a Supervised Program of Swallowable Intragastric Balloon-Analysis of 486 Patients in a High-Volume Bariatric Centre in Malaysia

Kosai NR 1 , Ali AA 2 , Ghita R 3 , Muthkumaran G 1 , Ali I 1 , Loo GH 1 Show all authors , Hayati F 4

Affiliations 

  • 1 Department of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000, Kuala Lumpur, Cheras, Malaysia
  • 2 Department of Surgery, Indira Gandhi Memorial Hospital, 20402, Malé, Republic of Maldives
  • 3 Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK
  • 4 Department of Surgery, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, 88450, Kota Kinabalu, Sabah, Malaysia. [email protected]
Obes Surg, 2024 Jul 23.
PMID: 39042306 DOI: 10.1007/s11695-024-07414-y

Abstract

INTRODUCTION: The swallowable intragastric balloon (IGB) has recently emerged as a popular alternative for weight loss in Malaysia. It can reduce total body weight loss (TBWL) by 6-15%. We aim to observe positive weight loss up to a year after the swallowable IGB is implanted.

METHODS: A total of 486 consecutive patients with overweight or obesity who underwent swallowable IGB insertion were included in this prospective data collection.

RESULTS: Out of 486 patients, 404 patients (83%) had complete data at the end of 4 and 12 months. Patients included in the study had a starting mean body mass index of 35.3 ± 7.2 kg/m2 which decreased to 31.5 ± 5.7 kg/m2 (p 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications